Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Diagnostic Criteria for Diabetes and Gestational Diabetes Mellitus

Standard Diagnostic Criteria

  • The American Diabetes Association recommends that the test should be performed in the morning after an overnight fast of at least 8 hours 1, 2
  • For standard diabetes diagnosis, a 75-g glucose load dissolved in water is administered, as recommended by the American Diabetes Association 1, 3
  • Blood samples are collected at baseline (fasting) and 2 hours after glucose consumption, according to the American Diabetes Association guidelines 1, 4
  • The diagnosis of diabetes is made when fasting plasma glucose is ≥126 mg/dL or 2-hour plasma glucose is ≥200 mg/dL, as defined by the American Diabetes Association 3, 4

Gestational Diabetes Mellitus Diagnostic Criteria

  • The American College of Obstetricians and Gynecologists recommends performing a 75-g OGTT at 24-28 weeks of gestation in pregnant women not previously diagnosed with diabetes 2, 5
  • Blood samples are collected when fasting and at 1 and 2 hours after glucose consumption, as recommended by the American College of Obstetricians and Gynecologists 2, 6
  • The diagnosis of GDM is made when any of the following plasma glucose values are met or exceeded: fasting ≥92 mg/dL, 1 hour ≥180 mg/dL, or 2 hour ≥153 mg/dL, according to the American College of Obstetricians and Gynecologists guidelines 2, 5

Important Considerations for Diagnostic Testing

  • The American Heart Association recommends that the test should be performed using venous plasma samples for standardization 8
  • For patients with conditions affecting red blood cell turnover, only plasma glucose criteria should be used, as recommended by the American Diabetes Association 1
  • A1C testing should be performed using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized to the Diabetes Control and Complications Trial (DCCT) assay, according to the American Diabetes Association guidelines 1, 3

Special Populations and Screening Recommendations

  • The American College of Obstetricians and Gynecologists recommends that screening for GDM should occur at 24-28 weeks of gestation in pregnant women 2, 4
  • Women with GDM should be screened for persistent diabetes at 6-12 weeks postpartum, as recommended by the American Diabetes Association 7, 9
  • Women with a history of GDM should have lifelong screening for diabetes or prediabetes at least every 3 years, according to the American Diabetes Association guidelines 7, 9
  • The American Diabetes Association states that the efficacy of interventions for primary prevention of type 2 diabetes has primarily been demonstrated among individuals with impaired glucose tolerance (IGT) 1